The global funding pipeline, 2017-2023: A review
Dear All, In a thoughtful companion to WHO’s preclinical and clinical pipeline reviews, we now have an instructive analysis of the global funding pipeline for
7 February 2026
No Comments
John Rex
FDA RFPs: Susceptibility breakpoints and external controls for invasive fungal infections
Dear All, I just today learned that FDA has posted two antimicrobial resistance-related (AMR-related) FY 2026 funding opportunities. The titles for the RFPs are very
5 February 2026
No Comments
Two new oral drugs for gonorrhea!
Dear All (wonkish … but worth it … get ready to follow the links!), Greetings in the new year! As a marvelous way to end
13 January 2026
No Comments
CARB-X Novel Chemistry for AMR Challenge
Dear All, Happy New Year! As a great start for January, Team CARB-X have announced (i) that they will have two funding calls during 2026 (April
8 January 2026
No Comments
The threat of mirror bacteria: Ongoing conversations (2025 wrap-up)
Dear All, Regular readers will be aware of the global conversation now happening around the threat arising from the potential to create viable organisms that
22 December 2025
No Comments
Natural product-inspired antibiotics: 1943-2025
Dear All, In a paper that is clearly a labor of love (1,032 references!), Mark Butler and Robert Capon have summarized the history of 217
16 December 2025
No Comments
Horizon Europe Work Programme 2026-2027: Calls of interest!
Dear All, Our colleagues in Europe have been busy! Along with yesterday’s announcement about transferrable exclusivity vouchers, we also had publication of the Horizon Europe
12 December 2025
No Comments
Pull incentives in Europe: TEVs to be included in legislative update
Dear All, There are more details yet to come, but the EU Council (“the Council”) and the EU Parliament (EP) yesterday announced an agreement on
12 December 2025
No Comments
Help design GAMRIC 2026! Webinar on Tue 16 Dec
Note: As always, please use the copy of the newsletter posted at https://amr.solutions/ if you have trouble with links in this newsletter. Dear All, As I
12 December 2025
No Comments
Phage therapy: Further notes related to the recent TATFAR paper
Dear All, The 8 Dec 2025 newsletter entitled “Phage therapy: Regulatory perspectives from TATFAR” generated a fair bit of commentary! I’ve now added several post-newsletter
11 December 2025
No Comments